Tscan Therapeutics IncTCRX
Price$0.31

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value not published yet, our data-reliability standards weren't met; method estimates belowbased on filings through 30 Jun 2026
Market Price $0.31Price as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 4.4%/yr (balance of the path).4.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 64.4%Yr 74.5%Yr 84.5%Yr 94.5%Yr 104.5%
4.4% → 4.5%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.4%Yr 124.2%Yr 134.1%Yr 143.9%Yr 153.8%Yr 163.6%Yr 173.5%Yr 183.3%Yr 193.2%Yr 203.0%
4.5% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Discount rate (cost of equity) 9.6%
Volatility vs market (adjusted beta)1.04

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetTscan Therapeutics IncTCRXHealth Care
Valuation
P/E—
P/S3.0×
P/B0.6×
EV / Revenue1.9×
EV / EBITDA—
Profitability
Gross margin29.4%
Operating margin-2,967.3%
Net margin-1,655.4%
FCF margin-1,665.6%
Returns
ROE-170.6%
ROA-68.7%
ROIC—
Growth
Revenue growth (YoY)152.5%
5-yr fwd EPS growth4.5%
Financial strength
Debt / Equity0.47×
Current ratio3.37×
Altman Z-Score-6.2
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.